Collateral

Article

Article

Updates Ready: Reboot Necessary

Clinical trials are now more complex than ever, and technology has not kept pace. Though a shift to digital decentralization has begun, all too often the solutions are just stitched onto already underperforming legacy systems.

Read more on The Medicine Maker

Article

Article

Getting the right tech tools vital to decentralized trial transition

Mark Tomlinson, Senior Director of Technology Operations at encapsia, explains how taking stock of existing tech and adding the right new tools can help when switching to virtual clinical studies.

Read more on Outsourcing Pharma

Article

Article

Enabling Decentralized Clinical Trials through Digital Transformation

To properly support and enable DCTs, we must undergo a digital transformation; we must eliminate the pain involved in aggregating and integrating data from multiple sources, reduce the lag between data capture and data analysis, and improve the ability of study teams to gain deeper insights and operationalize the data.

Read more on Contract Pharma

Article

Article

Personalized Medicine: A Work in Progress

Advances in big-data analytics are increasingly being employed to extract targeted information with the potential to drive life-sciences research and clinical practice closer to the goal of personalized and precision medicine.

Read more on PharmaVoice

Article

Article

Clinical Trials in 3D - DCT, Data Science and Digital Transformation

This article is taken from International Clinical Trials May 2021, pages 50-52. © Samedan Ltd.